Four awarded grants from a call that has received more applications than ever before

Success of the Bellvitge Biomedical Research Institute (IDIBELL) in the call for Marie Skłodowska-Curie individual fellowships (MSCA-IF), granted by the European Commission last Monday 29th. Of the 17 proposals submitted by the institute, the Commission has awarded 4 fellowships – worth 640,000 euros – to postdoctoral researchers, a historic milestone (success rate of 23.5%) that has been achieved the year that received the most proposals so far, 9,089.

The IDIBELL postdoctoral researchers distinguished by the European Commission are:

• Dr. Caroline Mauvezin, Cancer and Metabolism research group (Oncobell) – Supervisor: Dr. Albert Tauler
• Dr. Robert Carreras, Colorectal Cancer research group (Oncobell) – Supervisor: Dr. Víctor Moreno
• Dr. Hellen Kelly, Cancer Epidemiology research group – Supervisor: Dr. Silvia de San José (Cancer Epidemiology)
• Dr. Lourdes Farré, Chemotherapy and orthotopic xenografts research group (Oncobell) – Supervisor: Dr. Alberto Villanueva

The average evaluation score of the 4 winners was 94.60 out of 100.

The Marie-Curie fellowships, a successful story

Since 1994, the European Union has supported the work of 110,000 researchers of different disciplines through the Marie Skłodowska-Curie Actions program. In this edition, which has received 9,089 proposals, 1,348 researchers have been selected with projects dedicated to anti-corruption policies, the consequences of global warming, supercomputers, the search for new strategies against viruses and many others.

The funding, which is part of EU’s Horizon 2020 program for research and innovation, has a total value of 248.7 million euros – an increase of 30 million euros compared to the previous call – and aims to boost the careers of the fellowship recipients and make their projects have a positive impact on our society and economy.